Zanubrutinib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 546 publications
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.
Journal: Journal of medical economics
Published: January 19, 2026
Zanubrutinib for the treatment of cutaneous relapse of systemic marginal zone lymphoma: A case report.
Journal: JAAD case reports
Published: January 16, 2026
Immunotherapies in chronic immune-mediated neuropathies.
Journal: Handbook of clinical neurology
Published: January 12, 2026
Efficacy and Safety of Zanubrutinib in B-Cell Malignancies: A Single-Arm Meta-Analysis.
Journal: American journal of therapeutics
Published: January 08, 2026
Zanubrutinib for Immunoglobulin A Vasculitis With Monoclonal Gammopathy.
Journal: JAMA dermatology
Published: January 07, 2026
Cutaneous Infiltration as an Indicator of Systemic Disease Progression in Waldenström Macroglobulinemia.
Journal: International journal of dermatology
Published: December 08, 2025
Management of autoimmune hemolytic anemia.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data.
Journal: Journal of managed care & specialty pharmacy
Published: December 03, 2025
Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.
Journal: Annals of hematology
Published: December 02, 2025
Recurrent fever, persistent cytopenia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 27, 2025
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia Presenting as a Nasopharyngeal Mass With Bilateral Otitis Media With Effusion: A Case Report.
Journal: Cureus
Published: October 26, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
Journal: Hematological oncology
Published: October 18, 2025
Last Updated: 02/24/2026